Russian Heart Failure Journal 2008year Possibilities of using omega-3 polyinsaturated fatty acids for secondary prevention in patients with heart failure of ischemic etiology. Design of study «ONICS»


To access this material please log in or register

Register Authorize
2008/

Possibilities of using omega-3 polyinsaturated fatty acids for secondary prevention in patients with heart failure of ischemic etiology. Design of study «ONICS»

Arbolishvili G.N., Mareev V.Yu.

Keywords:

DOI:

Increased risk of sudden death (SD) is the major factor which compromises the prognosis in patients with MI. In recent decades much progress has been achieved in prevention of SD due to the use of implantable cardioverter defibrillators (ICD). These devices provide reduction in the risk of all-cause mortality by 30% in patients with postinfarction cardiosclerosis and pronounced systolic dysfunction. However the use of ICD in routine clinical practice is limited because of very high cost of this treatment while antiarrhythmics are much less effective and have substantial restrictions. Formulations of concentrated and highly purified ω-3 polyunsaturated fatty acids (PUFA) are a treatment which in combination with standard optimal therapy would reduce the risk of SD. The present review analyzes the effect of PUFA on SD rate in patients with IM and CHF and their role in secondary prevention of IHD.
    1.    Braunwald E. Evolution of the management of acute myocardial infarction: a 20th century saga. Lancet. 1998;352 (9142):1771–1774.
    2.    Heart Disease and Stroke Statistics – 2006 Update, American Heart Association. http://www.americanheart.org /­/ downloadable / heart / 1136308648540Statupdate2006. pdf
    3.    Moss AJ, Zareba W, Hall WJ et al: the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346 (12):877–883.
    4.    Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999;354 (9177):447–455.
    5.    Pound EM, Kang JX, Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res. 2001;42 (3):346–351.
    6.    Kang JX, Leaf A. Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci U S A. 1996;93 (8):3542–3546.
    7.    McLennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmia and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol. 1985;63 (11):1411–1417.
    8.    McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J. 1992;123 (6):1555–1561.
    9.    Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation. 1999;99 (18):2452–2457.
    10.    Nair SS, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr. 1997;127 (3):383–393.
    11.    Leaf A, Kang JX. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr. 2000;71 (1 Suppl):202S-207S.
    12.    Christensen JH, Gustenhof P, Korup E et al. Effects of fsh oil on heart rate variability in survivors of myocardial infarction: a double blind randomized controlled trial. BMJ. 1996;312 (7032):677–678.
    13.    Christensen JH, Skou HA, Fog L et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation. 2001;103 (5):651–657.
    14.    Christensen JH, Gustenhoff P, Eilersen E, et al. n-3 fatty acids and ventricular extra systoles in patients with ventricular tachyarrhythmias. Nutr Res. 1995;15:1–8.
    15.    von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985;76 (4):1626–1631.
    16.    Mehta J, Lawson D, Saldeen TJ. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J. 1988;116 (5 Pt 1):1201–1206.
    17.    Schrepf R, Limmert T, Weber C et al. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet. 2004;363 (9419):1441–1442.
    18.    Leaf A, Albert C, Josrphson M et al. Prevention of fatal arrhythmias in high risk subjects by fish oil acid intake. Circulation. 2005;112 (18):2762–2768.
    19.    Brouwer I, Zock P, Camm AJ et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295 (22):2613–2619.
    20.    Raitt M, Connor W, Morris C et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293 (23):2884–2891.
    21.    Uretsky BF, Thygesen K, Armstrong PW et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000;102 (6):611–616.
    22.    Macchia A, Levantesi G, Franzosi MG et al, for the GISSI-Prevenzione Investigators. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail. 2005;7 (5):904–909.

To access this material please log in or register

Register Authorize
Ru En